Net Loss of Kaya reported to Rs 99.20 crore in the quarter ended March 2024 as against net loss of Rs 56.37 crore during the previous quarter ended March 2023. Sales rose 3.19% to Rs 95.55 crore in the quarter ended March 2024 as against Rs 92.60 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 129.22 crore in the year ended March 2024 as against net loss of Rs 116.47 crore during the previous year ended March 2023. Sales rose 7.30% to Rs 404.25 crore in the year ended March 2024 as against Rs 376.73 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales95.5592.60 3 404.25376.73 7 OPM %-84.65-26.74 --10.96-6.57 - PBDT-83.76-40.85 -105 -66.62-56.14 -19 PBT-99.23-56.37 -76 -129.65-116.26 -12 NP-99.20-56.37 -76 -129.22-116.47 -11 Powered by Capital Market - Live News

Kaya will hold a meeting of the Board of Directors of the Company on 27 May 2024Powered by Capital Market - Live News

Net Loss of Kaya reported to Rs 8.28 crore in the quarter ended December 2023 as against net loss of Rs 17.79 crore during the previous quarter ended December 2022. Sales rose 2.39% to Rs 102.39 crore in the quarter ended December 2023 as against Rs 100.00 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales102.39100.00 2 OPM %11.562.14 - PBDT7.15-2.53 LP PBT-8.40-17.77 53 NP-8.28-17.79 53 Powered by Capital Market - Live News

Kaya will hold a meeting of the Board of Directors of the Company on 30 January 2024.Powered by Capital Market - Live News

Kaya announced that Kaya Middle East DMCC (DMCC), the material subsidiary of the Company has entered into definitive agreements to sell its entire holding in Minal Medical Centre LLC (MMC) and M M C Skin Clinic LLC (MMCSC), to Dr. Minal Patwardhan. The said transaction is completed.Consequently MMC & MMCSC ceases to be the subsidiaries of DMCC. Powered by Capital Market - Live News